StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) stock

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$74.18−3.48 (-4.48%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Inhibrx Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Inhibrx Biosciences's price to book ratio was 235.7× on Apr 30, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 1.0× to 235.7×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 2026235.7×+204.6
2025Dec 31, 202531.1×+29.8
2024Dec 31, 20241.2×−2.2
2023Dec 29, 20233.5×−2.7
2022Jul 29, 20226.2×−8.5
2021Dec 31, 202114.7×+11.3
2020Dec 31, 20203.4×–

More Inhibrx Biosciences figures

See a number that looks wrong?